Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
They can't disclose any material information at the show... so if there is anything new they want to discuss at the show it will have to be PR'ed tomorrow morning.
My feeling is that nothing new will be released.
EXCELLENT FIND NASDAQ
If IPCI is not on the map by November... this meeting will do it.
Hopefully the PODRAS patent will be approved by then... with all the news on opioids and overdosing I can see IPCI's PODRAS tecnology hitting the evening news... maybe even a news expose dedicated to IPCI's technology... oh what the heck... might as well put it on 60 minutes where it belongs.
Egalet and Collegium are also presenting, so a lot of it is on Abuse Deterrence Formulations - ADFs... but IPCI's PODRAS is about the holy grail of opioids abuse.
Others presenting -
Grunenthal USA - http://www.grunenthal.us/grt-web/GRT-US-WEB_Home/TRF/en_US/136700388.jsp;jsessionid=9DF6EE41C28483A0A2407E9C1DA007CD.drp1
Braeburn - markets PROBUPHINE which is medication for opioid addiction - not an IPCI competitor - https://braeburnpharmaceuticals.com/opioid-dependence-recovery/about/
ENSYSCE Bioscience - these guys are all pre-clinical, except one phase 1 trial - yearrrrrsssss for them to catch up. - http://www.ensysce.com/pipeline-pain/
3. IPCI will file an NDA for Rexista PODDS.
4-A. IPCI will announce a partnership for Rexista PODDS with a nice up-front milestone payment and contract will/may take into consideration partnering Rexista PODDS + PODRAS, whose research is totally funded by IPCI's partner.
4-B. IPCI shareholders meet in Las Vegas for $10.00+ party.
5. IPCI will announce a Regabatin partnership with a nice up front milestone payment - partner will fund all forward research.
IPCI shareholders live happily ever-after!!!
20K shares now will make you a millionaire in 3 to 5 years.
I think you're not understanding what "fast track" is
Don't get me wrong... it's a big plus in expediting the approval of a drug... but it does not entitle you to skip any required steps in the approval process... it does however, more readily, give you availability to FDA input... and probably the greatest asset is that you can feed the FDA partial packets of information as they become available... a "rolling submission," so that when you submit the last packet of information, they may well have already reviewed all the previous packets. It expedites the approval process... but it does not eliminate any steps.
On a psychological level...
Sorry Noodle, Fast track designation does not eliminate any trials and tribulations required in order to file an NDA, but it does mean the FDA will work closely with IPCI and expedite any meetings and paperwork reviews required... and most of all it cuts the PDUFA date down to 6 months rather than the customary 10 months.
I'm also not sure they would not need to start with a phase 1 study, as that is the phase which primarily focuses on safety... after all IPCI claims that they can give a lethal dose of the drug without affecting the patient... you don't prove that in phase 3... you prove it, and very slowly and carefully, in phase 1 where you dose 1 person, wait to see results... dose 2 people, wait to see results... dose 4 people etc. etc... luckily, unlike cancer, we don't need to wait months or years to see results - you dose the first patient at night... and if he wakes up in the morning... you're good to go dose the next 2... LOL.
Would you be so kind as to explain it to Samsa???
Hey guys... guys....... listen to this........ It just came to me today.... while I was sitting on the toilet... and I'm going to share it with you all.
I didn't know this yesterday...... but I know it now............ and now, I also know that what I know now I didn't know yesterday!!!!
I'm going to share it with everybody here... but don't spread it around too much...... because then it may stoppppp working... I think... I'm not sure... I don't know..... but ... anyway... this is it!!!
FIRST... buy 60K shares of IPCI
SECOND... sell 20K shares of IPCI ... are you starting to get it huhhh???? huhhh????
That's right!!! you got it!!! If the price goes up... you make money on the 60K shares... AAANNNNDDDD... if the price goes down ... thadahhhhm!!!! YOU MAKE MONEY ON THE 20K SHARES - yeeessss!!!
You CAN'T LOSE!!!
NOW!!! who's in for the IPCI $10.00 Las Vegas party???
Thanxs for the link Mopar
The NDA filing won't do that... but the right Partnership can do that and more - I'm hoping for a $300 to $400 million total package on Rexista PODDS with further milestone quantifyers on +PODRAS
Excellent DD numbers.
Everything you say is true... what I have to go on is that the previous CFO said he "believed" they had first to file rights on one dosage... perhaps it's wishful thinking but perhaps there are things we don't know like for instance that some companies have negotiated to be able to market "before" Seroquel actually goes off patent.
I don't know, except I know what Shameze said... it would be a nice surprise... but I'm not holding my breath waiting to know for sure.
What I consider most important in the near future is PODRAS patent and Rexista and Regabatin partnerships.
http://www.wallstreet-online.de/diskussion/1207106-211-220/intellipharmaceutics-ipci-hot-stock-2015-2016#neuster_beitrag
Open that link in Google and it will ask you if you want to translate it.
I was afraid to say it, or write it, and I was hoping it would go away... but that's what is usually done, most of the time.
What about the additional 15K options exercisable at C$2.88 ($2.16) and 75K options exercisable at C$3.25 ($2.43) expiring on November 30th 2016??? have they been extended???
Great catch ahasja
It's going to be very interesting to see how this is handled.
The way I read it, is that a combined 5,527,880 shares expire worthless by Sept 10 - a week from now - unless something major happens... because they certainly would not exercise the options and pay US$3.62 for a stock selling at half that on the open market.
And if there was a pop in the stock price... where are the Odidi's going to get $20,010,925.60 to pay for the shares.
Although the shares could have been specified that say the stock price is $5.00, then 5,527,880 x $5.00 per share = $27,639,400 total value of shares MINUS $20,010,925.60 cost of optioned shares = $7,628,474.40 OWED to the Odidis DIVIDED by $3.62 = 2,107,313 shares which would be issued to the Odidis, and the rest surrendered as payment for the whole amount... but I believe that it would require that the options were written up as such.
I have warrants from a private placement I did, that state that I can exercise the warrants and request that the difference between the stock price and the strike price be issued in shares - so there is no outlay of capital on my part.
Anyway it will be interesting to see how this is handled.
Also... an additional 15K options exercisable at C$2.88 and 75K options exercisable at C$3.25 expire on November 30th 2016
Close
IPCI = -1.68%
COLL = -7.34%
EGLT = -5.90%
Update
IPCI = -3.35%
COLL = -6.56%
EGLT = -6.58%
For those who might think IPCI is selling off today... just want to point out that IPCI is right now down 3.35% while Eagalet is down 3.98% and Collegium is down 4.34%.
What you are seeing is the selling by those "traders" who bought with the intentions of selling the news for a quick profit.
My guess is that not a single IPCI "investor" has sold a single share today.
It would certainly clarify the statement "turning good news into bad news" and the boiler plate warning of "not knowing if screening will resume", no need for screening to resume if FDA grants approval based on submitted data.
As usual, well thought out and insightful post Fabius... chock-full-of-wisdom... Please allow me to embellish it some.
unprecedented" epidemic of opioid painkiller overdose deaths.
http://www.aol.com/article/2016/08/26/the-surgeon-general-just-sent-a-worrisome-letter-to-every-doctor/21459520/
overdosing on prescription painkillers like oxycodone, fentanyl, and morphine.
Special to The Life Sciences Report (5/11/16)
The key for us over the next three months is to file the NDA for Rexistaâ„¢. We anticipate an FDA PDUFA action date within a six-month period, or by early 2017. We believe achieving this important milestone would open up other doors for the Intellipharmaceutics, particularly when it comes to securing credible partnering opportunities leading to the commercialization of Rexistaâ„¢ on terms that are favorable or acceptable to us.
You would not say "on terms that are favorable or acceptable to us" unless you had already had offers that were NOT favorable or acceptable to them.
IPCI "may," "will," "should," "expects," "plans," "plans to," "anticipates," "intends," to develop certain products which Angelo "believes," "estimates," "predicts," 20K shares today "could," "potentially," "make," you a Millionaire in 3 to 5 years!!!
I've made a number of assumptions in the preparation of my forward-looking statements. You should not place undue reliance on my forward-looking statements, which are subject to a multitude of known and unknown risks and uncertainties that could cause actual results, future circumstances or events to differ materially from those stated in or implied by my forward-looking statements."
Boy this waiting for Godot is painful... kinda wish I could fall asleep and wake up in 3 to 5 years to see if my "beliefs," "estimates," "predictions," come to fruition.
Excellent post numbers - chock full of researched information and logical thinking.
Can/would you give us your assessment on Rexista's potential and what is your gut feeling re: the partnership structure.
I'm not surprised that they have not yet partnered Keppra... it is the least valuable one in their pipeline with at most a 25% potential of each of the rest of the indications... and as you can see by the delay in the Rexista NDA filing... TIME is at a premium as well as money.
I would not be surprised to see a total package done where one up-and-coming Generic Wholesaler/Distributor takes on the whole portfolio.
I think the key right now is a partnership on Rexista and or Regabatin... that... will totally change the landscape.